Measurement of acetylcholine release in freely moving rats by means of automated intracerebral dialysis.
The present study demonstrates the feasibility of measuring acetylcholine in perfusion samples collected by means of in vivo brain dialysis in the striata of freely moving rats. The output of the dialysis device was directly connected to an automated sample valve of a HPLC-assay system that comprises a cation exchanger, a post-column enzyme reactor, and an electrochemical detector. The presence of an acetylcholinesterase inhibitor (neostigmine) in the perfusion fluid was required for the detection of acetylcholine in the perfusate. Increasing concentrations of neostigmine induced increasing amounts of acetylcholine. Continuous perfusion with a fixed concentration (2 microM) of neostigmine resulted in gradually increasing amounts of collected acetylcholine over time although a considerable variation between successive samples exists. The brain dialysis technique was further validated by studying the effect of various drugs. Systemically administered atropine increased the output of acetylcholine, whereas the addition of tetrodotoxin to the perfusion fluid resulted in a complete disappearance of the neurotransmitter.
D000109:Acetylcholine / Q000378:metabolism*; D000818:Animals; D001285:Atropine / Q000494:pharmacology; D001921:Brain / Q000201:enzymology / Q000378:metabolism*; D002800:Cholinesterase Inhibitors / Q000494:pharmacology; D003956:Dialysis / Q000379:methods; D008297:Male; D009043:Motor Activity; D009388:Neostigmine / Q000494:pharmacology; D009994:Osmolar Concentration; D010095:Oxotremorine / Q000494:pharmacology; D051381:Rats; D011919:Rats, Inbred Strains; D013779:Tetrodotoxin / Q000494:pharmacology; D013997:Time Factors
D002800:Cholinesterase Inhibitors; D009388:Neostigmine; D013779:Tetrodotoxin; D010095:Oxotremorine; D001285:Atropine; D000109:Acetylcholine